Orlando Methadone Treatment is categorized under Drug Abuse and Addiction Treatment in Orlando, FL .
Orlando Methadone Treatment was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Drug Abuse and Addiction Treatment business, which does work in the B2C market, and is classified as a Drug Abuse and Addiction Treatment, under code number 8133190 by the NAICS.
If you are seeking more information, feel free to contact Zeke Newsome, Executive Director at the company’s single location by writing to 601 South Semoran Boulevard, Orlando, Florida FL 32807 or by phoning (407) 275-8939. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Orlando Methadone Treatment |
Contact Person: | Zeke Newsome, Executive Director |
Address: | 601 South Semoran Boulevard, Orlando, Florida 32807 |
Phone Number: | (407) 275-8939 |
Annual Revenue (USD): | Unknown |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Drug Abuse and Addiction Treatment |
SIC Code: | 8399 |
NAICS Code: | 8133190 |
Share This Business: |
Orlando Methadone Treatment was started in 0 to provide professional Drug Abuse and Addiction Treatment under the SIC code 8399 and NAICS code 8133190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Zeke Newsome, Executive Director for inquiries that concern Orlando Methadone Treatment by calling the company number (407) 275-8939, as your correspondence is most welcome. Additionally, the physical location of the single location of Orlando Methadone Treatment can be found at the coordinates 28.53563,-81.31041 as well as the street address 601 South Semoran Boulevard in Orlando, Florida 32807.
For its online presence, you may visit Orlando Methadone Treatment’s website at and engage with its social media outlets through on Twitter and on Facebook.